Description
- Qanti® Breast Ki-67 is designed to assist anatomic pathologists in the quantitative cell counts and Ki-67 proliferation index in breast cancer.
Scoring System
- Proliferation index (Positive tumor cell / Total tumor cell)
- Following International Ki-67 Breast Cancer Working Group Recommendation
Performance
- Internal: 0.979 (correlation coefficient from QuaCCa-BRS Ki-67)
- External: 0.957 (correlation coefficient from BCData)
Certified by MFDS(K-FDA)
Qanti® Breast ER, PR, HER2, and Ki-67 modules have been approved as 'Qanti® IHC' by the Korean Ministry of Food and Drug Safety.
Pathology Visions 2025
